Journal Article Summary
The article explores the experiences of women and their partners with the levonorgestrel-releasing intrauterine system (LNG-IUS) in Kenya, a contraceptive method that is not widely used in sub-Saharan Africa. The study is significant because many women in this region wish to avoid or delay pregnancy but face barriers to accessing effective contraceptive methods. Understanding user experiences and perceptions can help improve the availability and acceptance of the LNG-IUS, especially as a more affordable version is anticipated to be introduced.
The researchers conducted qualitative interviews with 29 women who were current or recent users of the LNG-IUS, along with 9 of their male partners, to gather insights about their attitudes and experiences. The findings revealed that women chose the LNG-IUS primarily due to its perceived lower side effects compared to other contraceptive methods. Most participants reported positive experiences, highlighting the convenience, effectiveness, and reduced menstrual bleeding associated with the LNG-IUS. However, some women did express concerns about the insertion discomfort and the high cost of the method.
Despite the valuable insights gained, the study has limitations, including a sample that consisted mainly of educated professionals, which may not reflect the broader Kenyan population. This could affect the generalizability of the findings to women of lower socioeconomic status. Patients considering the LNG-IUS should discuss their options with healthcare professionals, particularly regarding potential side effects and the method's suitability for their individual needs. Understanding these factors can help ensure informed decision-making and enhance patient safety.
Medication Safety Note
This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.
Article Cited
- Nanda Geeta, Rademacher Kate, Solomon Marsden, Mercer Sarah, Wawire Jim, Ngahu Rose. Experiences with the levonorgestrel-releasing intrauterine system in Kenya: qualitative interviews with users and their partners. The European Journal of Contraception & Reproductive Health Care 2018. DOI: 10.1080/13625187.2018.1499892. PMID: 30198796. PMCID: PMC6191886.
Featured Pill Pals Product
OPill (O-Pill) Norgestrel Tablets 0.075 mg Daily Oral Contraceptive (Birth Control) --- Perrigo --- Over The Counter
OPill (O-Pill) Norgestrel Tablets 0.075 mg Daily Oral Contraceptive (Birth Control) — Perrigo — Over The Counter is available through Pill Pals Pharmacy with cash-pay pharmacy pricing and free shipping where available. This is an Over The Counter Product, so no prescription is required.However, your prescriber can still write for it as a prescription, if desired.
